國家衛生研究院 NHRI:Item 3990099045/5592

NHRI > Institute of Biotechnology and Pharmaceutical Research > Jinq-Chyi Lee > Periodical Articles > Item 3990099045/5592

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/5592

Title:	Development of sodium-dependent glucose co-transporter 2 inhibitors as potential anti-diabetic therapeutics
Authors:	Ho, LT;Kulkarni, SS;Lee, JC
Contributors:	Institute of Biotechnology and Pharmaceutical Research
Abstract:	The kidney plays an important role in the regulation of plasma glucose. It is estimated that greater than 99% of the renal glucose filtered by kidney glomerulus is resorbed by sodium-dependent glucose co-transporters (SGLTs), and that SGLT2 located in the proximal renal tubule achieves the most of this assignment. Studies of SGLT2 inhibitors indicate that raising renal glucose excretion by inhibiting SGLT2 helps effectively normalize the plasma glucose levels in individuals with type 2 diabetes mellitus (T2DM). This review discusses the discovery of SGLT2 inhibitors and the related structure-activity relationship (SAR) studies. The clinical trial data of dapagliflozin is also involved.
Date:	2011-06
Relation:	Current Topics In Medicinal Chemistry. 2011 Jun;11(12):1476-1512.
Link to:	http://dx.doi.org/10.2174/156802611795860915
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1568-0266&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000291636800006
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=79959969142
Appears in Collections:	[Jinq-Chyi Lee] Periodical Articles

Files in This Item:

File	Description	Size	Format
PUB21510836.pdf		2046Kb	Adobe PDF	758	View/Open